Jeffrey M. Leiden
2015 - Vertex Pharmaceuticals
|Non-Equity Incentive Plan||$3,463,200|
Leiden received $16.3M in option awards, accounting for 57.96% of the total pay in 2015.
Leiden also received $3.5M in non-equity incentive plan, $1.3M in salary, $7M in stock awards and $13.1K in other compensation.
43out of 13,593
Jeffrey M. Leiden's 2015 compensation ranked 43rd out of 13,593 executive pay records tracked by us this year.
Leiden earned more than 99.7% of all executives tracked by us in 2015.
Ranking in industry group
7out of 1,485
In the industry group of Drugs, Leiden's pay ranked 7th out of 1,485 executive pay records tracked by us in 2015.
Leiden earned more than 99.5% of executives in this group.
We found four more compensation records of executives who worked with Jeffrey M. Leiden at Vertex Pharmaceuticals in 2015.